Evidence of lower oxidative stress in the air spaces of patients with reversible COPD

International Journal of Immunopathology and Pharmacology

Volumn 19, Issue 3, 2006, Pages 617-628

  Serviddio, G ^a   Carpagnano, G E ^a   Rollo, T ^a   Tamborra, R ^a   Foschino Barbaro, M P ^a   Vendemiale, G ^b   Altomare, Emanuele ^a  

^a UNIVERSITY OF FOGGIA   (Italy)

^b CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

Author keywords

COPD; Glutathione; Inflammation; Oxidative stress; 2 agonist reversibility

Indexed keywords

GLUTATHIONE; INTERLEUKIN 4; INTERLEUKIN 6; SALBUTAMOL; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AIRFLOW; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; EOSINOPHIL COUNT; FEMALE; HUMAN; MALE; OXIDATION; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PRIORITY JOURNAL; SPUTUM ANALYSIS;

EID: 33750087574     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463200601900318     Document Type: Article

References (40)

1. Celli B.R., G. Snider, J. Heffner, B. Tiep, I. Ziment, B. Make, S. Braman, G. Olsen and Y. Philips. 1995. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease: American Thoracic Society. Am. J. Respir. Crit. Care Med. 152:77.
2. Siafakas N.M., P. Vermeire, N.B. Pride, P. Paoletti, J. Gibson, P. Howard, J.C. Yernault, M. Decramer, T. Higenbottam and D.S. Postma. 1995. Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task Force. Eur. Respir. J. 8:1398.
3. Senior R. and S. Shapiro. 1998. Chronic obstructive pulmonary disease: Epidemiology, pathophysiology and pathogenesis. In Fishman's pulmonary diseases and disorders. Fishman A.P., Elias J.A., Fishman J.A. et al, ed. McGrawhill, p. 659.
4. Kerstjens H.A., P.L. Brand, M.D. Hughes, N.J. Robinson, D.S. Postma, H.J. Sluiter, E.R. Bleecker, P.N. Dekhuijzen, P.M. de Jong, H.J. Mengelers et al. 1992. A comparison of bronchodilator therapy with or without inhaled corticosteroid therapy for obstructive airways disease. Dutch Chronic Non-Specific Lung Disease Study Group. N. Engl. J. Med. 20:1413.
5. Keatings V.M., A. Jatakanon, Y.M. Worsdell and P.J. Barnes. 1997. Effects of inhaled and oral glucocorticoids on inflammatory indices in asthma and COPD. Am. J. Respir. Crit. Care Med. 2:542.
6. Sluiter H.J., G.H. Koeter, J.G. de Monchy, D.S. Postma, K. de Vries and N.G. Orie. 1991. The Dutch hypothesis (chronic non-specific lung disease) revisited. Eur. Respir. J. 4:479.
7. Vestbo J. and E. Prescott. 1998. Update on the "Dutch hypothesis" for chronic respiratory disease. Thorax 53(S):15.
8. Crapo R.O. 1991. Spirometry: quality control and reproducibility criteria. Am. Rev. Respir. Dis. 6:1212.
9. American Thoracic Society. 1995. Standardization of spirometry. Am. J. Respir. Crit. Care Med. 152:1107.
10. Anthonisen N.R. and E.C. Wright. 1986. Bronchodilator response in chronic obstructive pulmonary disease. Am. Rev. Respir. Dis. 5:814.
11. Callahan C.M., R.S. Dittus and B.P. Katz. 1991. Oral corticosteroid therapy for patients with stable chronic obstructive pulmonary disease. A meta-analysis. Ann. Intern. Med. 3:216.
12. Saetta M., W. Timens and P.K. Jeffery. 1998. Pathology. In Management of of chronic obstructive pulmonary disease. In Postma DS, Siafakas NM editors, ed. p. 92.
13. Rodriguez-Roisin R. and W. MacNee. 1998. Pathophysiology of chronic obstructive pulmonary disease. In Management of chronic obstructive pulmonary disease. In Postma D.S., Siafakas N.M. editors, ed. p. 107.
14. Papi A., M. Romagnoli, S. Baraldo, F. Braccioni, I. Guzzinati, M. Saetta, A. Ciaccia and L.M. Fabbri. 2000. Partial reversibility of airflow limitation and increased exhaled NO and sputum eosinophilia in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 5:1773.
15. Tashkin D. and S. Kesten. 2003. Long-term treatment benefits with tiotropium in COPD patients with and without short-term bronchodilator responses. Chest 5:1441.
16. Elias J. 2004. The relationship between asthma and COPD. Lessons from transgenic mice. Chest 126:111.
17. Sitkauskiene B., R. Sakalauskas, K. Malakauskas and J. Lotvall. 2003. Reversibility to a beta2-agonist in COPD: relationship to atopy and neutrophil activation. Respir. Med. 6:591.
18. Repine J.E., A. Bast and I. Lankhorst. 1997. Oxidative stress in chronic obstructive pulmonary disease. Oxidative Stress Study Group. Am. J. Respir. Crit. Care Med. 1:341.
19. Strachan D.P., B.D. Cox, S.W. Erzinclioglu, D.E. Walters and M.J. Whichelow. 1991. Ventilatory function and winter fresh fruit consumption in a random sample of British adults. Thorax 9:624.
20. Kelly F.J., A. Blomberg, A. Frew, S.T. Holgate and T. Sandstrom. 1996. Antioxidant kinetics in lung lavage fluid following exposure of humans to nitrogen dioxide. Am. J. Respir. Crit. Care Med. 1:1700.
21. Vachier I., M. Damon, C. Le Doucen, A.C. de Paulet, P. Chanez, F.B. Michel and P. Godard. 1992. Increased oxygen species generation in blood monocytes of asthmatic patients. Am. Rev. Respir. Dis. 1:1161.
22. Chanez P., G. Dent, T. Yukawa, P.J. Barnes and K.F. Chung. 1990. Generation of oxygen free radicals from blood eosinophils from asthma patients after stimulation with PAF or phorbol ester. Eur. Respir. J. 9:1002.
23. Cluzel M., M. Damon, P. Chanez, J. Bousquet, A. Crastes de Faulet, F.B. Michel and P. Godard. 1987. Enhanced alveolar cell luminol-dependent chemiluminescence in asthma. J. Allergy Clin. Immunol. 2:195.
24. Schock B.C., I.S. Young, V. Brown, P.S. Fitch, M.D. Shields and M. Ennis. 2003. Antioxidants and oxidative stress in BAL fluid of atopic asthmatic children. Pediatr. Res. 3:375.
25. Celli B.R. and W. MacNee. 2004. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur. Respir. J. 6:932.
26. Carpagnano G.E., O. Resta, M.P. Foschino-Barbaro, A. Spanevello, A. Stefano, G. Di Gioia, G. Serviddio and E. Gramiccioni. 2004. Exhaled Interleukine-6 and 8-isoprostane in chronic obstructive pulmonary disease: effect of carbocysteine lysine salt monohydrate (SCMC-Lys). Eur. J. Pharmacol. 3:169.
27. Serviddio G., N. Di Venosa, A. Federici, D. D'Agostino, T. Rollo, F. Prigigallo, E. Altomare, T. Fiore and G. Vendemiale. 2005. Brief hypoxia before normoxic reperfusion (postconditioning) protects the heart against ischemia-reperfusion injury by preventing mitochondria peroxyde production and glutathione depletion. FASEB J. 3:354.
28. Tietze F. 1969. Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues. Anal. Biochem. 3:502.
29. Sacchetta P., D. Di Cola and G. Federici. 1986. Alkaline hydrolysis of N-ethylmaleimide allows a rapid assay of glutathione disulfide in biological samples. Anal. Biochem. 1:205.
30. Bland J.M. and D.G. Altman. 1996. Measurement error. B.M.J. 7059:744.
31. Perng D.W., H.Y. Huang, H.M. Chen, Y.C. Lee and R.P. Perng. 2004. Characteristics of airway inflammation and bronchodilator reversibility in COPD: a potential guide to treatment. Chest 2:375.
32. Rahman I. 2000. Regulation of nuclear factor-kappa B, activator protein-1, and glutathione levels by tumor necrosis factor-alpha and dexamethasone in alveolar epithelial cells. Biochem. Pharmacol. 8:1041.
33. Saetta M., A. Di Stefano, G. Turato, F.M. Facchini, L. Corbino, C.E. Mapp, P. Maestrelli, A. Ciaccia and L.M. Fabbri. 1998. CD8+ T-lymphocytes in peripheral airways of smokers with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 1:822.
34. Ray A. and L. Cohn. 1999. Th2 cells and GATA-3 in asthma: new insights into the regulation of airway inflammation. J. Clin. Invest. 8:985.
35. Babior B.M. 1978. Oxygen-dependent microbial killing by phagocytes (first of two parts). N. Engl. J. Med 12:659.
36. Drost E.M., C. Selby, S. Lannan, G.D. Lowe and W. MacNee. 1992. Changes in neutrophil deformability following in vitro smoke exposure: mechanism and protection. Am. J. Respir. Cell Mol. Biol. 3:287.
37. Postma D.S., T.E. Renkema, J.A. Noordhoek, H. Faber, H.J. Sluiter and H. Kauffman. 1988. Association between nonspecific bronchial hyperreactivity and superoxide anion production by polymorphonuclear leukocytes in chronic air-flow obstruction. Am. Rev. Respir. Dis. 1:57.
38. Sedgwick J.B., R.F. Vrtis, M.F. Gourley and W.W. Busse. 1988. Stimulus-dependent differences in superoxide anion generation by normal human eosinophils and neutrophils. J. Allergy Clin. Immunol. 1:876.
39. Stuehr D.J. 1999. Mammalian nitric oxide synthases. Biochim. Biophys. Acta 3:217.
40. Nathan C. and Q.W. Xie. 1994. Nitric oxide synthases: roles, tolls, and controls. Cell 6:915.